Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2017

09.06.2017 | Original Article

Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group

verfasst von: Darwin L. Conwell, Peter A. Banks, Bimaljit S. Sandhu, Stuart Sherman, Samer Al-Kaade, Timothy B. Gardner, Michelle A. Anderson, C. Mel Wilcox, Michele D. Lewis, Thiruvengadam Muniraj, Christopher E. Forsmark, Gregory A. Cote, Nalini M. Guda, Ye Tian, Joseph Romagnuolo, Stephen R. Wisniewski, Randall Brand, Andres Gelrud, Adam Slivka, David C. Whitcomb, Dhiraj Yadav

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Background/Objectives

Our aim was to validate recent epidemiologic trends and describe the distribution of TIGAR-O risk factors in chronic pancreatitis (CP) patients.

Methods

The NAPS-2 Continuation and Validation (NAPS2-CV) study prospectively enrolled 521 CP patients from 13 US centers from 2008 to 2012. CP was defined by definitive changes in imaging, endoscopy, or histology. Data were analyzed after stratification by demographic factors, physician-defined etiology, participating center, and TIGAR-O risk factors.

Results

Demographics and physician-defined etiology in the NAPS2-CV study were similar to the original NAPS2 study. Mean age was 53 years (IQR 43, 62) with 55% males and 87% white. Overall, alcohol was the single most common etiology (46%) followed by idiopathic etiology (24%). Alcohol etiology was significantly more common in males, middle-aged (35–65 years), and non-whites. Females and elderly (≥65 years) were more likely to have idiopathic etiology, while younger patients (<35 years) to have genetic etiology. Variability in etiology was noted by participating centers (e.g., alcohol etiology ranged from 27 to 67% among centers enrolling ≥25 patients). Smoking was the most commonly identified (59%) risk factor followed by alcohol (53%), idiopathic (30%), obstructive (19%), and hyperlipidemia (13%). The presence of multiple TIGAR-O risk factors was common, with 1, 2, ≥3 risk factors observed in 27.6, 47.6, and 23.6% of the cohort, respectively.

Conclusion

Our data validate the current epidemiologic trends in CP. Alcohol remains the most common physician-defined etiology, while smoking was the most commonly identified TIGAR-O risk factor. Identification of multiple risk factors suggests CP to be a complex disease.
Literatur
1.
Zurück zum Zitat Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology. 2008;8:520–531.CrossRefPubMedPubMedCentral Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology. 2008;8:520–531.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Somogyi L, Martin SP, Venkatesan T, et al. Recurrent acute pancreatitis: an algorithmic approach to identification and elimination of inciting factors. Gastroenterology. 2001;120:708–717.CrossRefPubMed Somogyi L, Martin SP, Venkatesan T, et al. Recurrent acute pancreatitis: an algorithmic approach to identification and elimination of inciting factors. Gastroenterology. 2001;120:708–717.CrossRefPubMed
3.
4.
5.
Zurück zum Zitat Cote GA, Yadav D, Slivka A, et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:266–273. (quiz e27).CrossRefPubMed Cote GA, Yadav D, Slivka A, et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:266–273. (quiz e27).CrossRefPubMed
6.
Zurück zum Zitat Yadav D, Slivka A, Sherman S, et al. Smoking is underrecognized as a risk factor for chronic pancreatitis. Pancreatology. 2010;10:713–719.CrossRefPubMed Yadav D, Slivka A, Sherman S, et al. Smoking is underrecognized as a risk factor for chronic pancreatitis. Pancreatology. 2010;10:713–719.CrossRefPubMed
7.
Zurück zum Zitat Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 2010;42:S381–S406.CrossRefPubMed Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 2010;42:S381–S406.CrossRefPubMed
8.
Zurück zum Zitat Spanier B, Bruno MJ, Dijkgraaf MG. Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995–2005. World J Gastroenterol. 2013;19:3018–3026.CrossRefPubMedPubMedCentral Spanier B, Bruno MJ, Dijkgraaf MG. Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995–2005. World J Gastroenterol. 2013;19:3018–3026.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Dominguez-Munoz JE, Lucendo A, Carballo LF, et al. A Spanish multicenter study to estimate the prevalence and incidence of chronic pancreatitis and its complications. Rev Esp Enferm Dig. 2014;106:239–245.PubMed Dominguez-Munoz JE, Lucendo A, Carballo LF, et al. A Spanish multicenter study to estimate the prevalence and incidence of chronic pancreatitis and its complications. Rev Esp Enferm Dig. 2014;106:239–245.PubMed
10.
Zurück zum Zitat De-Las-Heras-Castano G. The study of chronic pancreatitis epidemiology—the big challenge. Rev Esp Enferm Dig. 2014;106:237–238.PubMed De-Las-Heras-Castano G. The study of chronic pancreatitis epidemiology—the big challenge. Rev Esp Enferm Dig. 2014;106:237–238.PubMed
11.
Zurück zum Zitat Hirota M, Shimosegawa T, Masamune A, et al. The seventh nationwide epidemiological survey for chronic pancreatitis in Japan: clinical significance of smoking habit in Japanese patients. Pancreatology. 2014;14:490–496.CrossRefPubMed Hirota M, Shimosegawa T, Masamune A, et al. The seventh nationwide epidemiological survey for chronic pancreatitis in Japan: clinical significance of smoking habit in Japanese patients. Pancreatology. 2014;14:490–496.CrossRefPubMed
12.
Zurück zum Zitat Levy P, Dominguez-Munoz E, Imrie C, et al. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United Eur Gastroenterol J. 2014;2:345–354.CrossRef Levy P, Dominguez-Munoz E, Imrie C, et al. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United Eur Gastroenterol J. 2014;2:345–354.CrossRef
13.
Zurück zum Zitat Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707.CrossRefPubMed Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707.CrossRefPubMed
14.
Zurück zum Zitat Aoun E, Chang CC, Greer JB, et al. Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS One. 2008;3:e2003.CrossRefPubMedPubMedCentral Aoun E, Chang CC, Greer JB, et al. Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS One. 2008;3:e2003.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J Gastroenterol. 2004;99:2256–2270.CrossRefPubMed Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J Gastroenterol. 2004;99:2256–2270.CrossRefPubMed
16.
17.
Zurück zum Zitat Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169:1035–1045.CrossRefPubMed Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169:1035–1045.CrossRefPubMed
18.
Zurück zum Zitat Burton F, Alkaade S, Collins D, et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther. 2011;33:149–159.CrossRefPubMed Burton F, Alkaade S, Collins D, et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther. 2011;33:149–159.CrossRefPubMed
19.
Zurück zum Zitat Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut. 2011;60:77–84.CrossRefPubMed Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut. 2011;60:77–84.CrossRefPubMed
20.
Zurück zum Zitat Amann ST, Yadav D, Barmada MM, et al. Physical and mental quality of life in chronic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort. Pancreas. 2013;42:293–300.CrossRefPubMedPubMedCentral Amann ST, Yadav D, Barmada MM, et al. Physical and mental quality of life in chronic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort. Pancreas. 2013;42:293–300.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Brand H, Diergaarde B, O’Connell MR, et al. Variation in the gamma-glutamyltransferase 1 gene and risk of chronic pancreatitis. Pancreas. 2013;42:836–840.CrossRefPubMedPubMedCentral Brand H, Diergaarde B, O’Connell MR, et al. Variation in the gamma-glutamyltransferase 1 gene and risk of chronic pancreatitis. Pancreas. 2013;42:836–840.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299.CrossRefPubMed Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299.CrossRefPubMed
24.
Zurück zum Zitat Skinner HA, Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol. 1982;43:1157–1170.CrossRefPubMed Skinner HA, Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol. 1982;43:1157–1170.CrossRefPubMed
26.
Zurück zum Zitat Apte MV, Wilson JS. Stellate cell activation in alcoholic pancreatitis. Pancreas. 2003;27:316–320.CrossRefPubMed Apte MV, Wilson JS. Stellate cell activation in alcoholic pancreatitis. Pancreas. 2003;27:316–320.CrossRefPubMed
27.
Zurück zum Zitat Talukdar R, Tandon RK. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol. 2008;23:34–41.CrossRefPubMed Talukdar R, Tandon RK. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol. 2008;23:34–41.CrossRefPubMed
28.
Zurück zum Zitat Christian JB, Bourgeois N, Snipes R, et al. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–897.CrossRefPubMed Christian JB, Bourgeois N, Snipes R, et al. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–897.CrossRefPubMed
29.
Zurück zum Zitat Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–1429.CrossRefPubMed Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–1429.CrossRefPubMed
Metadaten
Titel
Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group
verfasst von
Darwin L. Conwell
Peter A. Banks
Bimaljit S. Sandhu
Stuart Sherman
Samer Al-Kaade
Timothy B. Gardner
Michelle A. Anderson
C. Mel Wilcox
Michele D. Lewis
Thiruvengadam Muniraj
Christopher E. Forsmark
Gregory A. Cote
Nalini M. Guda
Ye Tian
Joseph Romagnuolo
Stephen R. Wisniewski
Randall Brand
Andres Gelrud
Adam Slivka
David C. Whitcomb
Dhiraj Yadav
Publikationsdatum
09.06.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4621-z

Weitere Artikel der Ausgabe 8/2017

Digestive Diseases and Sciences 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.